Article info
PDFOriginal research
Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis
- Correspondence to Dr Nobutaka Takahashi, Department of Gynecology, Shizuoka Cancer Center, Sunto-gun, Shizuoka, Japan; n.takahashi{at}scchr.jp
Citation
Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis
Publication history
- Received August 3, 2021
- Accepted October 13, 2021
- First published November 1, 2021.
Online issue publication
April 26, 2022
Article Versions
- Previous version (10 January 2022).
- Previous version (10 January 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.